
कृपया अन्य खोज का प्रयास करें
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah Tikva, Israel.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Pnina Fishman | 75 | 1994 | Founder, Chief Scientific Officer & Executive Chairman |
Ilan Cohn | 69 | 1994 | Co-Founder & Director |
Abraham Sartani | 76 | 2001 | Independent Director |
Nabil Hanna | 79 | - | Member of Scientific Advisory Board |
Yaacov Goldman | 68 | 2017 | External Independent Director |
Stephen A. Harrison | - | 2023 | Member of Clinical Advisory Board & Consulting Chief Medical Officer |
Guy Regev | 54 | 2011 | Independent External Director |
Arun J. Sanyal | - | - | Member of Clinical Advisory Board |
Scott L. Friedman | - | - | Member of Clinical Advisory Board |
Yoseph Bornstein | 64 | 2021 | Independent External Director |
Rifaat Safadi | - | - | Member of Clinical Advisory Board |
Kim Papp | - | - | Member of Clinical Advisory Board |
Salomon Stemmer | - | - | Member of Clinical Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है